亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis

医学 冈崎碎片 神经学 内科学 心脏病学 免疫组织化学 精神科 增殖细胞核抗原 真核细胞DNA复制
作者
Shuhei Okazaki,Takaaki Morimoto,Yoichiro Kamatani,Teppei Kamimura,Hatasu Kobayashi,Kouji H. Harada,Tsutomu Tomita,Aya Higashiyama,Jun Takahashi,Jyoji Nakagawara,Masatoshi Koga,Ḱazunori Toyoda,Kazuo Washida,Satoshi Saitô,Atsushi Takahashi,Makoto Hirata,Koichi Matsuda,Hideki Mochizuki,Michael Chong,Guillaume Paré,Martin O’Donnell,Tetsuro Ago,Jun Hata,Toshiharu Ninomiya,Martin Dichgans,Stéphanie Debette,Michiaki Kubo,Akio Koizumi,Masafumi Ihara
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:139 (2): 295-298 被引量:88
标识
DOI:10.1161/circulationaha.118.038439
摘要

◼ moyamoya disease ◼ RING finger domains ◼ stroke I schemic stroke (IS) is the leading cause of disability and early death in Asia, where large-artery atherosclerosis (LAA) attributable to intracranial stenosis is the predominant etiology.Recently, a large transethnic genome-wide association study identified 32 loci associated with IS 1 ; however, Asian-specific genetic determinants remain unknown.Moyamoya disease (MMD), a rare cerebrovascular disease endemic in East Asia, is associated with a susceptibility gene RNF213, and its dysregulation experimentally impairs cerebral perfusion. 2,3We hypothesized a more general role of RNF213 in IS and examined the association of the p.R4810K variant of the RNF213 gene, the founder variant for MMD for Japanese, Korean, and Chinese, 2 with IS and its subtypes.In this 2-stage case-control study, we analyzed data from 3 independent Japanese population studies with a total of 46 958 individuals of East Asian ancestry (17 752 cases and 29 206 controls).All study participants provided written informed consent, and the responsible ethics committees and the local ethics committee of the National Cerebral and Cardiovascular Center approved the study.Variables were compared by using the Student t test and χ 2 test as appropriate.Stroke subtypes were classified according to TOAST criteria (Trial of Org 10172 in Acute Stroke Treatment).In the primary stage, we examined the p.R4810K genotype using a single hospital-based population with clinical and radiological data (NCVC Biobank: 383 noncardioembolic stroke cases and 1011 controls), excluding patients with MMD (n=12).The RNF213 p.R4810K variant was found in 5.2% of patients with noncardioembolic stroke and in 2.1% of controls (odds ratio [OR], 2.60 [95% CI, 1.39-4.85],P=0.0019).When stratified by subtypes, only LAA was significantly associated with the variant (OR, 5.19 [95% CI, 2.53-10.64],P=2.6×10 -6 ).The mean age of stroke onset was lower in the variant carriers than noncarriers (58.1±15.5 years versus 69.1±13.2years, P=0.0003).The variant carriers included more women (55.0%versus 27.3%, P=0.011), and showed greater frequency of intracranial anterior circulation stenosis (60.0%versus 27.3%, P=0.004).We investigated whether the significant association was replicable.The p.R4810K genotypes were derived from genome-wide genotyping data in Biobank-Japan (16 256 IS cases and 27 294 controls), and the Hisayama and the Fukuoka Stroke Registry (FSR) study (1113 cases and 901 controls).We investigated the association between RNF213 R4810K and IS by imputed allele dosage of R4810K and fitted to logistic regression model with additive genetic model. 1 In the replication stage, the variant was found in 2.3% and 3.8% of patients with ischemic stroke and in 1.3% of both controls in the Biobank-Japan and Hisayama-FSR.In comparison with controls, the carrier frequency was significantly higher in all IS cases (OR, 1.77 [95% CI, 1.40-2.24],P=1.6×10 -6 in Biobank-Japan; OR, 2.90 [95% CI, 1.39-6.04],P=0.0045 in Hisayama-FSR), especially in those with LAA (OR, 3.10 [95% CI, 1.98-4.84],P=6.9×10 -7 in Biobank-Japan; OR, 4.20 [95%

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
20秒前
Kaikai发布了新的文献求助10
26秒前
34秒前
专注的从筠完成签到,获得积分10
40秒前
41秒前
Owen应助Kaikai采纳,获得10
1分钟前
研友_LMo56Z完成签到,获得积分10
1分钟前
1分钟前
在水一方应助大气大侠采纳,获得30
1分钟前
Kaikai发布了新的文献求助10
1分钟前
1分钟前
大气大侠发布了新的文献求助30
1分钟前
1分钟前
烂漫大地发布了新的文献求助10
1分钟前
赘婿应助breeze采纳,获得10
1分钟前
szx233完成签到 ,获得积分10
2分钟前
林韵悠扬完成签到 ,获得积分10
2分钟前
2分钟前
大刘大刘泊完成签到 ,获得积分10
2分钟前
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
3分钟前
Kao完成签到,获得积分10
3分钟前
breeze发布了新的文献求助10
3分钟前
3分钟前
科研通AI2S应助友好的乌采纳,获得10
3分钟前
任性天晴发布了新的文献求助10
3分钟前
任性天晴完成签到,获得积分10
3分钟前
Akim应助科研通管家采纳,获得10
4分钟前
Jasper应助Iris采纳,获得10
5分钟前
qin完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
SciGPT应助大药瓶子采纳,获得10
6分钟前
Petrichor完成签到,获得积分10
6分钟前
Copyright应助科研通管家采纳,获得10
6分钟前
ZHANG完成签到 ,获得积分10
6分钟前
6分钟前
7分钟前
Petrichor发布了新的文献求助10
7分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6968107
求助须知:如何正确求助?哪些是违规求助? 8649188
关于积分的说明 18340187
捐赠科研通 6422093
什么是DOI,文献DOI怎么找? 3088415
关于科研通互助平台的介绍 2140181
邀请新用户注册赠送积分活动 2064933